- OCGN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Ocugen (OCGN) 8-K27 Oct 21The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. populationFinancial data
Company Profile